Work

Using subcutaneous nerve stimulation to control atrial fibrillation

Year: 2025
Type: article
Study design: Clinical Trial
Abstract: Background Subcutaneous nerve stimulation (ScNS) can reduce atrial arrhythmia in canine models. Objective To test the hypothesis that ScNS can reduce the burden of paroxysmal atrial fibrillation (AF) by a randomized, sham-controlled clinical trial. Methods Patients with drug-resistant symptomatic paroxysmal AF were randomized to receive ScNS (10 Hz, 3.5 mA output, 20 s ON, and 1 min OFF) for two weeks. The AF burden was determined by ePatch recordings. Results Of the 46 consented, 12 (8 men and 4 women, 60.9 ± 10.2 years) were randomized. The change in AF burden at week 1 from eligibility week was not significantly different between the groups (p=0.8102). The proportion of AF-free patients was 16.7% for each group (p=1.000). The difference in difference (DID) estimates for weeks 1, 2, 3, and 12 (estimate ± SE) were -2.04 ± 10.84 (p=0.8516), -2.44 ± 10.84 (p=0.8228), -0.20 ± 10.84 (p=0.986), and -18.11 ± 11.16 (p=0.1126), respectively. The Stimulation Group shows a slower increase in %AF burden over time than the Sham group (p=0.027 for group and time interaction) when time is modeled linearly as a continuous variable in the mixed model. In Week 3, the ventricular rate (VR) during AF in the Stimulation Group was faster than in the Sham Group (p=0.026). Conclusions Two weeks of ScNS did not reduce the AF burden or control the ventricular rate in patients with paroxysmal AF. However, there was a slower increase in %AF burden over time in the Stimulation group than in the Sham group.
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,150
OpenAlex ID: W4416527897
FWCI: 0.629
Cites: 22
Cited by: 1
Related to: